SCICLONE PHARMACEUTICALS INC: cashflow_financing
| Value | {"amount": -24699000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-12-31 |
| Status | current |
| Entity | SCICLONE PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7bfc63d0-658e-41d7-af0d-7daa720ab039
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-13-136952Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000880771/cashflow-financing/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7bfc63d0-658e-41d7-af0d-7daa720ab039
History
- no predecessors — first report